Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Microbiol Res ; 236: 126455, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32179389

RESUMO

Echinenone and canthaxanthin are important carotenoid pigments with food and industrial applications. Biosynthesis of echinenone and/or canthaxanthin is catalyzed by ß-carotene ketolase (CrtO), with ß-carotene as the substrate. In this study, we generated transgenic Nostoc sp. PCC 7120 overexpressing a heterologous crtO gene from Nostoc flagelliforme and evaluated the productivity of both pigments. Normal (BG11 medium, 30 °C) and osmotic stress (BG11 medium supplemented with 0.4 M mannitol, 30 °C) conditions were used for cultivation. As compared to control strain, production of echinenone and canthaxanthin in transgenic strain were respectively increased by more than 16 % and 80 %, under either normal or osmotic stress conditions. Especially upon the stress condition, higher proportion of echinenone and canthaxanthin in total pigments was achieved, which should be beneficial for downstream separation and purification. In addition, transgenic strain showed drought tolerance and could revive from desiccation treatment after rewetting. Thus, this study provided technical clues for production of both pigments in engineered cyanobacteria as well as for cyanobacterial anhydrobiotic engineering.


Assuntos
Nostoc/genética , Organismos Geneticamente Modificados/crescimento & desenvolvimento , Organismos Geneticamente Modificados/metabolismo , Oxigenases/genética , Adaptação Fisiológica , Proteínas de Bactérias/genética , Cantaxantina/biossíntese , Carotenoides/metabolismo , Clonagem Molecular , Secas , Genes Bacterianos , Engenharia Metabólica/métodos , Nostoc/crescimento & desenvolvimento , Nostoc/metabolismo , Organismos Geneticamente Modificados/genética , Oxigenases/metabolismo , beta Caroteno/biossíntese
2.
Biotechnol Lett ; 39(7): 1049-1058, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28365881

RESUMO

OBJECTIVES: To engineer broad spectrum resistance in potato using different expression strategies. RESULTS: The previously identified Ribosome-Inactivating Protein from Phytolacca heterotepala was expressed in potato under a constitutive or a wound-inducible promoter. Leaves and tubers of the plants constitutively expressing the transgene were resistant to Botrytis cinerea and Rhizoctonia solani, respectively. The wound-inducible promoter was useful in driving the expression upon wounding and fungal damage, and conferred resistance to B. cinerea. The observed differences between the expression strategies are discussed considering the benefits and features offered by the two systems. CONCLUSIONS: Evidence is provided of the possible impact of promoter sequences to engineer BSR in plants, highlighting that the selection of a suitable expression strategy has to balance specific needs and target species.


Assuntos
Resistência à Doença , Expressão Gênica , Organismos Geneticamente Modificados/imunologia , Doenças das Plantas/prevenção & controle , Proteínas Recombinantes/metabolismo , Proteínas Inativadoras de Ribossomos/metabolismo , Solanum tuberosum/imunologia , Botrytis/imunologia , Botrytis/patogenicidade , Regulação da Expressão Gênica de Plantas , Organismos Geneticamente Modificados/genética , Phytolacca/enzimologia , Phytolacca/genética , Doenças das Plantas/microbiologia , Proteínas Recombinantes/genética , Rhizoctonia/imunologia , Rhizoctonia/patogenicidade , Proteínas Inativadoras de Ribossomos/genética , Solanum tuberosum/genética
3.
Plant Sci ; 240: 50-64, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26475187

RESUMO

Ent-labdane-related diterpene (ent-LRD) specialized (i.e. secondary) metabolites of the medicinal plant kalmegh (Andrographis paniculata) have long been known for several pharmacological activities. However, our understanding of the ent-LRD biosynthetic pathway has remained largely incomplete. Since ent-LRDs accumulate in leaves, we carried out a comparative transcriptional analysis using leaf and root tissues, and identified 389 differentially expressed transcripts, including 223 transcripts that were preferentially expressed in leaf tissue. Analysis of the transcripts revealed various specialized metabolic pathways, including transcripts of the ent-LRD biosynthetic pathway. Two class II diterpene synthases (ApCPS1 and ApCPS2) along with one (ApCPS1') and two (ApCPS2' and ApCPS2″) transcriptional variants that were the outcomes of alternative splicing of the precursor mRNA and alternative transcriptional termination, respectively, were identified. ApCPS1 and ApCPS2 encode for 832- and 817-amino acids proteins, respectively, and are phylogenetically related to the dicotyledons ent-copalyl diphosphate synthases (ent-CPSs). The spatio-temporal patterns of ent-LRD metabolites accumulation and gene expression suggested a likely role for ApCPS1 in general (i.e. primary) metabolism, perhaps by providing precursor for the biosynthesis of phytohormone gibberellin (GA). However, ApCPS2 is potentially involved in tissue-specific accumulation of ent-LRD specialized metabolites. Bacterially expressed recombinant ApCPS2 catalyzed the conversion of (E,E,E)-geranylgeranyl diphosphate (GGPP), the general precursor of diterpenes to ent-copalyl diphosphate (ent-CPP), the precursor of ent-LRDs. Taken together, these results advance our understanding of the tissue-specific accumulation of specialized ent-LRDs of medicinal importance.


Assuntos
Alquil e Aril Transferases/genética , Alquil e Aril Transferases/metabolismo , Andrographis/genética , Andrographis/metabolismo , Diterpenos/metabolismo , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Bactérias/genética , Bactérias/metabolismo , Redes e Vias Metabólicas , Dados de Sequência Molecular , Especificidade de Órgãos , Organismos Geneticamente Modificados/genética , Organismos Geneticamente Modificados/metabolismo , Filogenia , Folhas de Planta/metabolismo , Raízes de Plantas/metabolismo , Análise de Sequência de DNA
5.
Microb Ecol ; 68(4): 842-58, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25008981

RESUMO

A type II restriction-modification system was found in a native plasmid of Pseudomonas savastanoi pv. savastanoi MLLI2. Functional analysis of the methyltransferase showed that the enzyme acts by protecting the DNA sequence CTGCAG from cleavage. Restriction endonuclease expression in recombinant Escherichia coli cells resulted in mutations in the REase sequence or transposition of insertion sequence 1A in the coding sequence, preventing lethal gene expression. Population screening detected homologous RM systems in other P. savastanoi strains and in the Pseudomonas syringae complex. An epidemiological survey carried out by sampling olive and oleander knots in two Italian regions showed an uneven diffusion of carrier strains, whose presence could be related to a selective advantage in maintaining the RM system in particular environments or subpopulations. Moreover, carrier strains can coexist in the same orchards, plants, and knot tissues with non-carriers, revealing unexpected genetic variability on a very small spatial scale. Phylogenetic analysis of the RM system and housekeeping gene sequences in the P. syringae complex demonstrated the ancient acquisition of the RM systems. However, the evolutionary history of the gene complex also showed the involvement of horizontal gene transfer between related strains and recombination events.


Assuntos
Proteínas de Bactérias/genética , Evolução Biológica , Enzimas de Restrição-Modificação do DNA/genética , Pseudomonas/enzimologia , Pseudomonas/genética , Sequência de Aminoácidos , Proteínas de Bactérias/química , Proteínas de Bactérias/metabolismo , Enzimas de Restrição-Modificação do DNA/química , Enzimas de Restrição-Modificação do DNA/metabolismo , Elementos de DNA Transponíveis , Escherichia coli/genética , Transferência Genética Horizontal , Dados de Sequência Molecular , Nerium/microbiologia , Olea/microbiologia , Organismos Geneticamente Modificados/genética , Filogenia
6.
PLoS One ; 8(6): e67441, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23840703

RESUMO

Trypanosoma cruzi is the etiological agent of Chagas disease, an illness that affects about 10 million people, mostly in South America, for which there is no effective treatment or vaccine. In this context, transgenic parasites expressing reporter genes are interesting tools for investigating parasite biology and host-parasite interactions, with a view to developing new strategies for disease prevention and treatment. We describe here the construction of a stably transfected fluorescent T. cruzi clone in which the GFP gene is integrated into the chromosome carrying the ribosomal cistron in T. cruzi Dm28c. This fluorescent T. cruzi produces detectable amounts of GFP only at replicative stages (epimastigote and amastigote), consistent with the larger amounts of GFP mRNA detected in these forms than in the non replicative trypomastigote stages. The fluorescence signal was also strongly correlated with the total number of parasites in T. cruzi cultures, providing a simple and rapid means of determining the growth inhibitory dose of anti-T.cruzi drugs in epimastigotes, by fluorometric microplate screening, and in amastigotes, by the flow cytometric quantification of T. cruzi-infected Vero cells. This fluorescent T. cruzi clone is, thus, an interesting tool for unbiased detection of the proliferating stages of the parasite, with multiple applications in the genetic analysis of T. cruzi, including analyses of host-parasite interactions, gene expression regulation and drug development.


Assuntos
Proteínas de Fluorescência Verde/biossíntese , Trypanosoma cruzi/fisiologia , Animais , Chlorocebus aethiops , Avaliação Pré-Clínica de Medicamentos/métodos , Citometria de Fluxo , Fluorometria , Genes Reporter , Proteínas de Fluorescência Verde/genética , Interações Hospedeiro-Parasita , Concentração Inibidora 50 , Viabilidade Microbiana , Nitroimidazóis/farmacologia , Organismos Geneticamente Modificados/genética , Organismos Geneticamente Modificados/metabolismo , Organismos Geneticamente Modificados/fisiologia , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Células Vero
7.
Diagn Microbiol Infect Dis ; 75(3): 282-91, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23312610

RESUMO

Fluorescent and colorimetric reporter genes are valuable tools for drug screening models, since microscopy is labor intensive and subject to observer variation. In this work, we propose a fluorimetric method for drug screening using red fluorescent parasites. Fluorescent Leishmania amazonensis were developed after transfection with integration plasmids containing either red (RFP) or green fluorescent protein (GFP) genes. After transfection, wild-type (LaWT) and transfected (LaGFP and LaRFP) parasites were subjected to flow cytometry, macrophage infection, and tests of susceptibility to current antileishmanial agents and propranolol derivatives previously shown to be active against Trypanosoma cruzi. Flow cytometry analysis discriminated LaWT from LaRFP and LaGFP parasites, without affecting cell size or granulosity. With microscopy, transfection with antibiotic resistant genes was not shown to affect macrophage infectivity and susceptibility to amphotericin B and propranolol derivatives. Retention of fluorescence remained in the intracellular amastigotes in both LaGFP and LaRFP transfectants. However, detection of intracellular RFP parasites was only achieved in the fluorimeter. Murine BALB/c macrophages were infected with LaRFP parasites, exposed to standard (meglumine antimoniate, amphotericin B, Miltefosine, and allopurinol) and tested molecules. Although it was possible to determine IC(50) values for 4 propranolol derivatives (1, 2b, 3, and 4b), all compounds were considered inactive. This study is the first to develop a fluorimetric drug screening test for L. amazonensis RFP. The fluorimetric test was comparable to microscopy with the advantage of being faster and not requiring manual counting.


Assuntos
Avaliação Pré-Clínica de Medicamentos/métodos , Leishmania/efeitos dos fármacos , Proteínas Luminescentes/metabolismo , Testes de Sensibilidade Parasitária/métodos , Anfotericina B/farmacologia , Animais , Antiprotozoários/farmacologia , Relação Dose-Resposta a Droga , Citometria de Fluxo , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Concentração Inibidora 50 , Leishmania/genética , Leishmania/metabolismo , Proteínas Luminescentes/genética , Macrófagos/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Organismos Geneticamente Modificados/genética , Organismos Geneticamente Modificados/metabolismo , Propranolol/análogos & derivados , Propranolol/farmacologia , Reprodutibilidade dos Testes , Transfecção , Proteína Vermelha Fluorescente
8.
Appl Microbiol Biotechnol ; 96(1): 265-72, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22218771

RESUMO

To improve phosphorus removal from wastewater, we constructed a high-phosphate-accumulating microorganism, KTPPK, using Pseudomonas putida KT2440 as a host. The expression plasmid was constructed by inserting and expressing polyphosphate kinase gene (ppk) from Microcystis aeruginosa NIES-843 into broad-host-range plasmid, pBBR1MCS-2. KTPPK was then added to a sequencing batch biofilm reactor (SBBFR) using lava as a biological carrier. The results showed that SBBFR with KTPPK not only efficiently removed COD, NH(3)-N, and NO(3)(-)-N but also had a high removal capacity for PO(4)(3-)-P, resulting in a low phosphorus concentration remaining in the outflow of the SBBFR. The biofilm increased by 30-53% on the lava in the SBBFR that contained KTPPK after 11 days when compared with the reactor that contained P. putida KT2440. Real-time quantitative polymerase chain reaction confirmed that the copy of ppk was maintained at about 3.5 × 10(10) copies per µL general DNA in the biofilm after 20 days. Thus, the transgenic bacteria KTPPK could maintain a high density and promote phosphorus removal in the SBBFR. In summary, this study indicates that the use of SBBFR with transgenic bacteria has the potential to remove phosphorus and nitrogen from wastewater.


Assuntos
Biofilmes/crescimento & desenvolvimento , Engenharia Metabólica , Nitrogênio/metabolismo , Organismos Geneticamente Modificados/metabolismo , Fósforo/metabolismo , Fosfotransferases (Aceptor do Grupo Fosfato)/metabolismo , Pseudomonas putida/metabolismo , Reatores Biológicos/microbiologia , Perfilação da Expressão Gênica , Instabilidade Genômica , Microcystis/enzimologia , Microcystis/genética , Organismos Geneticamente Modificados/genética , Organismos Geneticamente Modificados/fisiologia , Fosfotransferases (Aceptor do Grupo Fosfato)/genética , Plasmídeos , Pseudomonas putida/genética , Pseudomonas putida/fisiologia , Reação em Cadeia da Polimerase em Tempo Real , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo
9.
Planta Med ; 77(18): 2003-12, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21800278

RESUMO

A series of naphthoquinones was tested for activity against both extracellular promastigote and intracellular amastigote Leishmania major GFP in vitro. In parallel, the compounds were evaluated for cytotoxic effects against bone marrow-derived macrophages (BMM Φ) as a mammalian host cell control. Most of the compounds noticeably inhibited the growth of extracellular parasites (IC (50) 0.5 to 6 µM) and the intracellular survival of L. major GFP amastigotes (IC (50) 1 to 7 µM) when compared with the antileishmanial drug amphotericin B (IC (50) of 2.5 and 0.2 µM, respectively). In general, antiprotozoal activity and host cell cytotoxicity seemed to increase in parallel. Conspicuously, the cytotoxic effect was less pronounced on infected host cells when compared with that on noninfected cells. Concerning structure/activity relationships for the tested naphthoquinones, some interesting structural features emerged from this study. Introduction of a methyl or methoxyl group at C-2 of the parent 1,4-naphthoquinone slightly increased the antileishmanial activity against clinically relevant amastigotes, while the presence of a hydroxyl function in this position dramatically reduced the effectiveness. In contrast, hydroxylation at C-5 and dihydroxy substitution at C-5 and C-8 significantly enhanced the antiprotozoal activity. Similarly, the presence of a side chain hydroxyl group PERI to a carbonyl function as represented in the series of shikonin/alkannin derivatives increased the activity when compared with substituted analogs. Within the series of naphthoquinones tested, the dimeric mixture of vaforhizin and isovaforhizin showed the highest activity IN VITRO against the clinically relevant intracellular amastigote with an IC (50) of 1.1 µM. With IC (50) values mostly in the range of 1-3 µM, the shikonin/alkannin derivatives proved to be similarly considerably leishmanicidal. None of the compounds tested was capable to induce NO production known to play a crucial role in the host resistance against intracellular pathogens, excluding activation of microbicidal mechanisms in macrophages. The mode of action apparently depended on the substitution pattern, associated with the electrophilicity of the naphthoquinone or the efficiency of redox cycling. Conspicuously, members oxygenated in the quinone ring proved to be leishmanicidal when coincubated with glutathione, while the majority of the remaining compounds lost activity.


Assuntos
Antiprotozoários/farmacologia , Leishmania/efeitos dos fármacos , Macrófagos/parasitologia , Naftoquinonas/farmacologia , Anfotericina B/farmacologia , Animais , Bignoniaceae/química , Boraginaceae/química , Meios de Cultura/química , Drosera/química , Citometria de Fluxo , Glutationa/farmacologia , Proteínas de Fluorescência Verde/química , Hidroxilação , Concentração Inibidora 50 , Leishmania/química , Leishmania/genética , Leishmania/patogenicidade , Macrófagos/efeitos dos fármacos , Mamíferos , Naftoquinonas/química , Organismos Geneticamente Modificados/genética , Testes de Sensibilidade Parasitária , Relação Estrutura-Atividade
10.
J Biol Chem ; 286(34): 29449-61, 2011 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-21622567

RESUMO

Selenoproteins are essential in vertebrates because of their crucial role in cellular redox homeostasis, but some invertebrates that lack selenoproteins have recently been identified. Genetic disruption of selenoprotein biosynthesis had no effect on lifespan and oxidative stress resistance of Drosophila melanogaster. In the current study, fruit flies with knock-out of the selenocysteine-specific elongation factor were metabolically labeled with (75)Se; they did not incorporate selenium into proteins and had the same lifespan on a chemically defined diet with or without selenium supplementation. These flies were, however, more susceptible to starvation than controls, and this effect could be ascribed to the function of selenoprotein K. We further expressed mouse methionine sulfoxide reductase B1 (MsrB1), a selenoenzyme that catalyzes the reduction of oxidized methionine residues and has protein repair function, in the whole body or the nervous system of fruit flies. This exogenous selenoprotein could only be expressed when the Drosophila selenocysteine insertion sequence element was used, whereas the corresponding mouse element did not support selenoprotein synthesis. Ectopic expression of MsrB1 in the nervous system led to an increase in the resistance against oxidative stress and starvation, but did not affect lifespan and reproduction, whereas ubiquitous MsrB1 expression had no effect. Dietary selenium did not influence lifespan of MsrB1-expressing flies. Thus, in contrast to vertebrates, fruit flies preserve only three selenoproteins, which are not essential and play a role only under certain stress conditions, thereby limiting the use of the micronutrient selenium by these organisms.


Assuntos
Expressão Gênica , Longevidade/fisiologia , Estresse Oxidativo/fisiologia , Oxirredutases/biossíntese , Selenoproteínas/biossíntese , Animais , Drosophila melanogaster , Metionina Sulfóxido Redutases , Camundongos , Proteínas dos Microfilamentos , Organismos Geneticamente Modificados/genética , Organismos Geneticamente Modificados/metabolismo , Oxirredução , Oxirredutases/genética , Selenoproteínas/genética
11.
Appl Biochem Biotechnol ; 165(2): 611-23, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21594593

RESUMO

Recombinant human platelet-derived growth factor-BB (rhPDGF-BB) is widely used in many therapeutic applications. Until now, there has been no report on rhPDGF-BB expressed in fungi. In this study, we tested whether Pleurotus eryngii could support the expression of human therapeutic rhPDGF-BB protein. A binary vector pCAMBIA1304 containing the hPDGF-BB gene was constructed and introduced into P. eryngii via Agrobacterium tumefaciens-mediated transformation. The transformation of hPDGF-BB gene was confirmed by Southern blot and PCR, whereas the expression was confirmed by Western blot analysis. The recombinant hPDGF-BB reached a maximum expression level of 1.98% of total soluble protein in transgenic mycelia and was in dimeric form. A bioassay revealed that hPDGF-BB expressed in P. eryngii increased proliferation of NIH-3T3 cells similarly to standard material. These results suggest that P. eryngii can be a robust system for the production of human therapeutic proteins including the hPDGF-BB.


Assuntos
Agrobacterium tumefaciens/genética , Fibroblastos/efeitos dos fármacos , Genômica/métodos , Organismos Geneticamente Modificados/genética , Fator de Crescimento Derivado de Plaquetas , Pleurotus/genética , Engenharia de Proteínas/métodos , Agrobacterium tumefaciens/metabolismo , Animais , Becaplermina , Southern Blotting , Western Blotting , Dimerização , Escherichia coli , Fibroblastos/metabolismo , Humanos , Camundongos , Células NIH 3T3 , Organismos Geneticamente Modificados/metabolismo , Plasmídeos , Fator de Crescimento Derivado de Plaquetas/genética , Fator de Crescimento Derivado de Plaquetas/isolamento & purificação , Fator de Crescimento Derivado de Plaquetas/metabolismo , Fator de Crescimento Derivado de Plaquetas/farmacologia , Pleurotus/metabolismo , Reação em Cadeia da Polimerase , Proteínas Proto-Oncogênicas c-sis , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia , Transdução Genética , Transformação Bacteriana
12.
Nat Biotechnol ; 29(2): 103-6, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21301429

RESUMO

With information on the Deepwater Horizon oil spill in the Gulf of Mexico still coming in, more is being learned about the role of indigenous bacteria in cleaning the spill. Meanwhile, efforts are under way to enlist new genomic technologies to improve outcomes. Jeffrey L. Fox reports.


Assuntos
Bactérias/metabolismo , Biodegradação Ambiental , Biotecnologia , Monitoramento Ambiental , Organismos Geneticamente Modificados/metabolismo , Bactérias/genética , Poluição Ambiental/prevenção & controle , Genômica , Organismos Geneticamente Modificados/genética , Petróleo/metabolismo
13.
Trends Microbiol ; 17(10): 439-43, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19758804

RESUMO

The market for N-glycosylated therapeutic proteins represents multi-billion dollars in sales and is growing more than 10% each year. This requires cost-effective production platforms that display correct and homogeneous N-glycosylation. Based on recent results, we propose to use mushroom-forming basidiomycetes for the production of N-glycosylated therapeutic proteins.


Assuntos
Agaricales/metabolismo , Produtos Biológicos/biossíntese , Organismos Geneticamente Modificados/metabolismo , Proteínas Recombinantes/biossíntese , Agaricales/genética , Produtos Biológicos/genética , Biotecnologia/métodos , Glicosilação , Modelos Biológicos , Organismos Geneticamente Modificados/genética , Proteínas Recombinantes/genética , Tecnologia Farmacêutica/métodos
14.
Biometals ; 22(6): 1051-61, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19649569

RESUMO

Pichia guilliermondii is a representative of yeast species that overproduce riboflavin (vitamin B2) in response to iron deprivation. P. guilliermondii YFH1 gene coding for frataxin homologue, eukaryotic mitochondrial protein involved in iron trafficking and storage, was identified and deleted. Constructed P. guilliermondii Δyfh1 mutant grew very poorly in a sucrose-containing synthetic medium supplemented with sulfate or sulfite as a sole sulfur source. Addition of sodium sulfide, glutathione, cysteine, methionine, N-acetyl-L-cysteine partially restored growth rate of the mutant suggesting that it is impaired in sulfate assimilation. Cellular iron content in Δyfh1 mutant was ~3-3.5 times higher as compared to the parental strain. It produced 50-70 times more riboflavin in iron sufficient synthetic media relative to the parental wildtype strain. Biomass yield of the mutant in the synthetic glutathione containing medium supplemented with glycerol as a sole carbon source was 1.4- and 2.6-fold increased as compared to sucrose and succinate containing media, respectively. Oxygen uptake of the Δyfh1 mutant on sucrose, glycerol or succinate, when compared to the parental strain, was decreased 5.5-, 1.7- and 1.5-fold, respectively. Substitution of sucrose or glycerol in the synthetic iron sufficient medium with succinate completely abolished riboflavin overproduction by the mutants. Deletion of the YFH1 gene caused hypersensitivity to hydrogen peroxide and exogenously added riboflavin and led to alterations in superoxide dismutase activities. Thus, deletion of the gene coding for yeast frataxin homologue has pleiotropic effect on metabolism in P. guilliermondii.


Assuntos
Proteínas Fúngicas/metabolismo , Proteínas de Ligação ao Ferro/metabolismo , Ferro/metabolismo , Organismos Geneticamente Modificados/metabolismo , Pichia/metabolismo , Riboflavina/farmacologia , Proteínas Fúngicas/genética , Deleção de Genes , Glicerol/metabolismo , Peróxido de Hidrogênio/farmacologia , Transporte de Íons/efeitos dos fármacos , Transporte de Íons/genética , Proteínas de Ligação ao Ferro/genética , Mitocôndrias/metabolismo , Organismos Geneticamente Modificados/genética , Pichia/genética , Riboflavina/biossíntese , Riboflavina/genética , Ácido Succínico/metabolismo , Sacarose/metabolismo , Compostos de Enxofre/metabolismo , Ésteres do Ácido Sulfúrico/metabolismo , Superóxido Dismutase/análise , Frataxina
15.
J Antimicrob Chemother ; 64(2): 370-4, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19525291

RESUMO

OBJECTIVES: Several Leishmania strains with episomal expression of green fluorescent protein (GFP) require constant drug pressure for its continuous expression and hence limit its use in ex vivo or in vivo systems. The aim of this study was to alleviate this problem by stably integrating the GFP gene into the parasite genome, so as to use these transfectants for ex vivo and in vivo drug screening. METHODS: The GFP gene was integrated downstream of the 18S ribosomal promoter region of Leishmania donovani. After initial selection, GFP-expressing parasites-both sodium stibogluconate (SAG)-susceptible (2001) and -resistant (2039) isolates-were grown without adding G418. The infectivity of these transfectants to macrophages (J774.1) as well as to hamsters was checked. The ex vivo screening assay was standardized using standard antileishmanial drugs. RESULTS: A constitutive and enhanced expression of GFP in promastigote and amastigote stages was achieved for approximately 12 months without any need for drug pressure. These transfectants were highly infective to macrophage cell lines as well as to hamsters, as observed by fluorescence microscopy and flow cytometry (FACS). GFP-tagged promastigotes as well as intracellular amastigotes were found to be highly susceptible to miltefosine, amphotericin B and pentamidine, in a concentration-dependent manner. SAG was inactive against the GFP-promastigotes, as well as SAG-resistant intracellular amastigotes, correlating well with earlier reports. CONCLUSIONS: The GFP-transfectants were found to be suitable for FACS-based ex vivo screening assays. They were also infective to hamsters up to day 60 post-infection.


Assuntos
Avaliação Pré-Clínica de Medicamentos/métodos , Avaliação Pré-Clínica de Medicamentos/normas , Leishmania donovani/efeitos dos fármacos , Leishmania donovani/genética , Organismos Geneticamente Modificados/genética , Animais , Antiprotozoários/farmacologia , Cricetinae , Genes Reporter , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Leishmania donovani/patogenicidade , Leishmaniose Visceral/parasitologia , Macrófagos/parasitologia , Camundongos
16.
Pharmacogenomics ; 6(4): 383-92, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16004556

RESUMO

While significant advancements have been made in identifying the genes that comprise the human genome, considerable work remains in gaining an understanding of the functions of these gene products. Improved knowledge of protein function is of particular relevance to the drug discovery process, as the elucidation of new targets that are involved in disease processes will most probably lead to improvements in health care. Reverse genetic approaches that attempt to assign protein function on a gene-by-gene basis are labor intensive and have low throughput. Although forward genetic (function-to-gene) approaches often allow for the more efficient identification of disease-relevant drug targets, most existing methodologies are not capable of sampling the entire genome. Here we review current target discovery strategies and discuss two relatively new technologies, RAGE (random activation of gene expression) and GECKO (genome-wide cellular knockout). These tools provide cellular libraries that can be utilized in genome-wide target discovery screens. Examples are given of how these methodologies may facilitate the identification of new drug targets that are involved in human disease and pathology.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Avaliação Pré-Clínica de Medicamentos/métodos , Técnicas de Amplificação de Ácido Nucleico/métodos , Organismos Geneticamente Modificados/genética , Farmacogenética/métodos , Animais , Desenho de Fármacos , Genoma , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA